AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2014
Nov 26, 2014
284_dirs_2014-11-26_b032405d-6149-412a-b963-3e973f14044d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-11-26
Reporting Person: LAZARUS ROCHELLE B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-26 | Common Stock | M | 5000.0000 | $34.4400 | Acquired | 9595.0000 | Direct |
| 2014-11-26 | Common Stock | M | 5000.0000 | $33.8300 | Acquired | 14595.0000 | Direct |
| 2014-11-26 | Common Stock | S | 10000.0000 | $59.6300 | Disposed | 4595.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-26 | Stock Option (right to buy) | $34.4400 | M | 5000.0000 | Disposed | 2016-04-27 | Common Stock (5000.0000) | Direct |
| 2014-11-26 | Stock Option (right to buy) | $33.8300 | M | 5000.0000 | Disposed | 2015-04-28 | Common Stock (5000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1757.0000 | Indirect |
Footnotes
F1: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.
F2: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30